Substances

Shulgin Farm and the Future of Psychedelic Drug Development

April 2, 2024
Featuring: Paul F. Daley, Ph.D.

In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds.

Subscribe Share

In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds.

He is now the co-founder, Chief Science Officer, and Director of Analytical Science at the Alexander Shulgin Research Institute (ASRI), focusing on the discovery and development of novel psychedelic compounds. While Sasha was passionate about self-experimentation, the Institute is aiming for the next step for these drugs: FDA approval.

He discusses:

  • Meeting Sasha at the 2nd international conference on hallucinogenic mushrooms in Washington D.C.
  • Bonding with Sasha while reviewing the autopsy of researcher Robert van den Bosch for possible foul play
  • The two compounds ASRI is closest to being able to test in clinical trials
  • The 5-HT2B receptor, risk of valvular disease, and why we will likely be hearing more about this going forward
  • How AI and new technology can lead to better safety science

and more!

Links

Shulginresearch.net

Shulginfoundation.org

Shulginfarm.org

The Pesticide Conspiracy, by Robert van den Bosch

The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds, by Alexander T. Shulgin, Tania Manning, Paul F. Daley

Drzee.org

Island, by Aldous Huxley

*Book links are affiliate links, meaning that Psychedelics Today will receive a percentage of the sale

Paul F. Daley_ Ph.D.

In this Episode

Paul F. Daley, Ph.D.

Paul F. Daley, Ph.D. has over 40 years of experience in analytical toxicology, entomology, plant physiology, and environmental restoration technology; over sixty peer-reviewed publications in integrated pest management, plant photosynthesis, environmental chemistry, analytical instrumentation, and the pharmacology of psychedelics. He was a career scientist at the Lawrence Livermore National Laboratory from 1984 to 2014 and is now the co-founder, Chief Science Officer, and Director of Analytical Science at the Alexander Shulgin Research Institute in Lafayette and Berkeley, CA, where work focuses on the discovery chemistry and development pharmacology of psychoactive and psychedelic drugs. With Alexander Shulgin and Tania Manning, he co-authored The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds, published by Transform Press in 2011.